e-GAB: Electronic Geriatric Assessment Bundle: Development of an Arabic Self-administered Android CGA Application

January 11, 2021 updated by: Doha Rasheedy, Ain Shams University
The aim of this study is to design and assess the accuracy of administering the electronic Geriatric Assessment Bundle (e-GAB) compared to geriatrician performed comprehensive geriatric assessment (CGA) in a group of Egyptian elderly. The development of an Arabic software platform for CGA can improve the clinical practice by providing a valid user friendly tool to collect and analyze data for geriatric patients attending non- Geriatric health care service.

Study Overview

Detailed Description

Modern geriatric care is based primarily on the concept of multidisciplinary approach of elderly care. This could be achieved by integrating CGA in different disciplines dealing with the older patient. CGA is different from that of the standard medical evaluation; it is a systematic evaluation of frail older adults. It uses combinations of validated geriatric tools to formulate an inventory of health problems, and develop an individualized geriatric intervention plan.

The software platform for CGA has been widely used in western countries; however, tools that can fit patients with different backgrounds should be implemented..

From the initial pool of 3 potential subtests, four experienced geriatricians developed a bundle of 15 subtests, to evaluate cognition, mood, vision, hearing, urinary continence, nutrition, functional capacity, fall risk and balance impairment, frailty, polypharmacy, sleep, pain, home safety, and social problems. Moreover, a rapid survey of medical and surgical conditions was obtained.

Initial evaluation of these subsets compared to the reference standard CGA was done. Each patient completed the bundle then underwent CGA by an experienced geriatrician blinded to the result of e-GAB

Study Type

Observational

Enrollment (Actual)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11566
        • Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

50 elderly patients completed the bundle then underwent CGA by an experienced geriatrician blinded to the result of e-GAB

Description

Inclusion Criteria:

  • 60 years or above
  • community dwelling
  • can read and write
  • can use the android application

Exclusion Criteria:

  • any patient refused to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
community dwelling elderly
community dwelling elderly patients (60 years or older), can read and write, able to use the android software applications
android application for comprehensive geriatric assessment
CGA by an experienced geriatrician blinded to the result of e-GAB

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the sensitivity and specificity of administering the electronic Geriatric Assessment Bundle (e-GAB)
Time Frame: the geriatrician will perform standard CGA within 30 minutes of e-GAB completion
assess sensitivity and specificity of the e-GAB for detecting the aforementioned conditions (e.g. Frailty, Depression, sleep disturbance, malnutrition, cognitive decline etc.. )compared to standard CGA
the geriatrician will perform standard CGA within 30 minutes of e-GAB completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

April 15, 2020

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

January 23, 2019

First Submitted That Met QC Criteria

December 24, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

January 13, 2021

Last Update Submitted That Met QC Criteria

January 11, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on e-GAB

Subscribe